Neurocrine Corp (NBIX) - Kapitalizatsiyaning foydaga nisbati

Neurocrine - NBIX emitenti grafik logotipi

Asosiy dori vositalari savdosidan tushadigan mablag'larning barqaror oqimi Neurocrine Biosciences (NBIX) kompaniyasiga moliyaviy barqarorlikni ta'minlaydi. P/E baholash koeffitsienti ushbu tendentsiyani aks ettiradi va ushbu ko'rsatkich 23.60 ga teng. Patentlar orqali diskineziya davolashdagi ustunlik premium daromadlarni kafolatlaydi. Biroq, geosiyosiy keskinliklar va xomashyo logistikasidagi uzilishlar global klinik sinovlarni o'tkazishni hamda komponentlar yetkazib berishni murakkablashtiradi.

neurocrine.com (NBIX): Narxning foydaga nisbati 04.07.2022dan 18.11.2026gacha

neurocrine.com (NBIX) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil

- joriy narx va aksiyalarning prognoz qilingan qiymati:
Kompaniyaning har tomonlama tahlili:Neurocrine Biosciences, Inc. - NBIX
Neurocrine Biosciences original mahsuloti

Investorlar Neurocrine Biosciences (NBIX) kompaniyasining barqarorligini bozor qiymati va haqiqiy daromadlar orasidagi nisbat prizmasi orqali bahlamoqdalar. Nevrologiya va endokrinologiya sohalaridagi yuqori R&D faoliyati kelajakdagi foydani klinik sinovlarning muvaffaqiyatiga bog'liq qiladi. Kompaniyaning P/E grafigida aks etgan bozor kapitalizatsiyasining umumiy yillik sof foydaga nisbati bir dollar foydaning tannarxini o'lchaydi. Ushbu metrika pipeline innovatsion salohiyati uchun to'langan premiumning miqdorini aniqlashga yordam beradi.

Muhim raqobatchilar

Narxning foydaga nisbati BIIB|P/E multiplikatori RGC|Axsome Corp - Narx-foyda multiplikatori|P/E multiplikatori ACAD (ACADIA Corp)|XENE: Narx-foyda multiplikatori|Viking Therapeutics Inc - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati Supernus Pharmaceuticals, Inc.|Catalyst Pharmaceuticals Inc (CPRX) - Narxning foydaga nisbati|DNLI (Denali Therapeutics Inc) - Narxning foydaga nisbati|Narxning foydaga nisbati Harmony Biosciences Holdings, Inc.|Narxning foydaga nisbati BHVN|Narx-foyda koeffitsiyenti AMLX (Amylyx Pharmaceuticals, Inc.)|Bozor narxining sof foydaga nisbati TRVI|Narxning foydaga nisbati Praxis Precision Medicines, Inc. PRAX|Anavex Corp - Narxning foydaga nisbati|CBLL: Narx-foyda koeffitsiyenti|Kompaniya qiymatining sof foydaga nisbati PRTA (prothena.com)|Alector, Inc. (ALEC) - Narxning foydaga nisbati|Narx-foyda multiplikatori ANNX|Narxning foydaga nisbati Omeros Corp.|Neurogene Therapeutics (NGNE) - Biznesning o‘zini qoplash muddati|P/E multiplikatori ACIU|VYGR (Voyager Therapeutics) - Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori NMRA (neumoratx.com)|SCLX: Narx-foyda multiplikatori|TVGN - Narxning foydaga nisbati|Kapitalizatsiyaning foydaga nisbati Alpha Cognition Inc.|CGTX: P/E multiplikatori|inhibikase.com (IKT) - P/E multiplikatori|Narxning foydaga nisbati Cassava Sciences Inc|ASRT - Kapitalizatsiyaning sof foydaga nisbati koeffitsiyenti|Narxning foydaga nisbati Coya (COYA)|P/E multiplikatori VistaGen Therapeutics Inc (VTGN)|Ovid Therapeutics Inc. - Narx-foyda koeffitsiyenti|Biznesning o‘zini qoplash muddati Acumen Pharmaceuticals (ABOS)|CervoMed Corporation - P/E multiplikatori|Biznesning o‘zini qoplash muddati alteritytherapeutics.com ATHE|CLNN: P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati PepGen Corp (PEPG)|Narxning foydaga nisbati Jupiter Neurosciences, Inc.|RLMD: Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori ANVS|Narx-foyda koeffitsiyenti Grace Tx GRCE|Narxning foydaga nisbati Firefly Neuroscience, Inc AIFF|KLTO: Narx-foyda multiplikatori|NRSN - Narxning foydaga nisbati|RVPH: Narxning foydaga nisbati|MTVA (MetaVia Inc.) - Narx-foyda koeffitsiyenti|NeurAxis Inc. (NRXS) - P/E multiplikatori|Narxning foydaga nisbati Helius Medical|Passage Bio, Inc. - Kapitalizatsiyaning sof foydaga nisbati|Narx-foyda koeffitsiyenti NEUP (Neuphoria)|NERV - Kapitalizatsiyaning foydaga nisbati|P/E multiplikatori ATHA (athira.com)|P/E multiplikatori Addex Therapeutics Ltd ADXN|Alzamend Neuro, Inc. - P/E multiplikatori|CYCN - P/E multiplikatori|PTIX (Protagenic Therapeutics, Inc.) - Narx-foyda koeffitsiyenti|Kapitalizatsiyaning foydaga nisbati Pasithea (KTTA)|Narxning foydaga nisbati Cortigent|Kapitalizatsiyaning foydaga nisbati Avenue Therapeutics Inc. ATXI|Narxning foydaga nisbati brainstorm-cell.com (BCLI)|Narx-foyda koeffitsiyenti Cara Therapeutics, Inc CARA|P/E multiplikatori CHRO (chromocell.com)|Kompaniya qiymatining sof foydaga nisbati ELYM|Intra-Cellular Therapies Inc. - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati Longboard Pharmaceuticals Inc|Marinus (MRNS) - Narxning foydaga nisbati|NKGN - Biznesning o‘zini qoplash muddati|Narxning foydaga nisbati NeuroBo Pharmaceuticals|SAGE: Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori SNPX|Trevena Inc. - Narx-foyda multiplikatori|Narxning foydaga nisbati Vigil Neuroscience, Inc. VIGL|Anew Medical, Inc. - Narxning foydaga nisbati|Cerevel Therapeutics - P/E multiplikatori